FAM
Fred Alger Management Portfolio holdings
AUM
$22.3B
1-Year Return
57.87%
This Quarter Return
+33.49%
1 Year Return
+57.87%
3 Year Return
+264.72%
5 Year Return
+406.03%
10 Year Return
+1,631.73%
AUM
$22.3B
AUM Growth
+$4.78B
(+27%)
Cap. Flow
+$230M
Cap. Flow
% of AUM
1.03%
Top 10 Holdings %
Top 10 Hldgs %
50.21%
Holding
486
New
68
Increased
145
Reduced
194
Closed
54
Top Buys
| 1 |
NBIS
Nebius Group N.V. Class A Ordinary Shares
NBIS
|
$244M |
| 2 |
Vistra
VST
|
$228M |
| 3 |
Roblox
RBLX
|
$149M |
| 4 |
Alphabet (Google) Class C
GOOG
|
$147M |
| 5 |
Constellation Energy
CEG
|
$134M |
Top Sells
| 1 |
Applovin
APP
|
$177M |
| 2 |
NRG Energy
NRG
|
$173M |
| 3 |
Netflix
NFLX
|
$150M |
| 4 |
Core Scientific
CORZ
|
$97.9M |
| 5 |
Broadcom
AVGO
|
$90.3M |
Sector Composition
| 1 | Technology | 34.53% |
| 2 | Communication Services | 19.7% |
| 3 | Consumer Discretionary | 14.06% |
| 4 | Industrials | 10.3% |
| 5 | Healthcare | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
351
Confluent
CFLT
$6.64B
| $1.16M | 0.01% |
+46,543
| New | +$1.16M |
|
352
Rocket Companies
RKT
$42.1B
| $1.15M | 0.01% |
+80,915
| New | +$1.15M |
|
353
Live Nation Entertainment
LYV
$37.8B
| $1.14M | 0.01% |
+7,556
| New | +$1.14M |
|
354
Commault Systems
CVLT
$7.89B
| $1.14M | 0.01% |
+7,513
| New | +$1.14M |
|
355
BridgeBio Pharma
BBIO
$10.2B
| $1.03M | ﹤0.01% |
23,799
-4,600
| -16% | -$199K |
|
356
Tango Therapeutics
TNGX
$777M
| $980K | ﹤0.01% |
+191,337
| New | +$980K |
|
357
Certara
CERT
$1.71B
| $978K | ﹤0.01% |
+83,590
| New | +$978K |
|
358
Teva Pharmaceuticals
TEVA
$21.6B
| $976K | ﹤0.01% |
+58,228
| New | +$976K |
|
359
Prime Medicine
PRME
$626M
| $946K | ﹤0.01% |
+383,194
| New | +$946K |
|
360
BILL Holdings
BILL
$5.19B
| $939K | ﹤0.01% |
20,291
+15,055
| +288% | +$696K |
|
361
Simulations Plus
SLP
$283M
| $936K | ﹤0.01% |
+53,628
| New | +$936K |
|
362
XPO
XPO
$15.3B
| $923K | ﹤0.01% |
7,309
-465
| -6% | -$58.7K |
|
363
Schrodinger
SDGR
$1.41B
| $904K | ﹤0.01% |
+44,950
| New | +$904K |
|
364
Collegium Pharmaceutical
COLL
$1.22B
| $903K | ﹤0.01% |
+35,249
| New | +$903K |
|
365
Autodesk
ADSK
$68.8B
| $897K | ﹤0.01% |
2,899
-108,045
| -97% | -$33.4M |
|
366
Embraer
ERJ
$11.1B
| $857K | ﹤0.01% |
15,051
+9,154
| +155% | +$521K |
|
367
MaxCyte
MXCT
$151M
| $850K | ﹤0.01% |
390,104
+669
| +0.2% | +$1.46K |
|
368
Skye Bioscience
SKYE
$122M
| $842K | ﹤0.01% |
+201,451
| New | +$842K |
|
369
Enovis
ENOV
$1.84B
| $802K | ﹤0.01% |
+29,500
| New | +$802K |
|
370
Alger AI Enablers & Adopters ETF
ALAI
$140M
| $779K | ﹤0.01% |
25,245
| – | – |
|
371
Oric Pharmaceuticals
ORIC
$1.08B
| $774K | ﹤0.01% |
76,286
-102,436
| -57% | -$1.04M |
|
372
Scholar Rock
SRRK
$3.09B
| $747K | ﹤0.01% |
+21,100
| New | +$747K |
|
|
KLC
373
KinderCare Learning Companies, Inc.
KLC
$866M
| $729K | ﹤0.01% |
72,207
-60
| -0.1% | -$606 |
|
374
Surgery Partners
SGRY
$2.87B
| $683K | ﹤0.01% |
+35,431
| New | +$683K |
|
375
Edwards Lifesciences
EW
$47.4B
| $663K | ﹤0.01% |
+8,483
| New | +$663K |
|